Претраживање
Приказ резултата 51-60 од 164
Development of chromatographic methods for analysis of sulfamethoxazole, trimethoprim, their degradation products and preservatives in syrup / Razvoj hromatografskih metoda za analizu sulfametoksazola, trimetoprima, njihovih degradacionih proizvoda i konzervanasa u sirupu
(Savez farmaceutskih udruženja Srbije, Beograd, 2014)
In this paper the experimental conditions for optimal reversed-phase liquid chromatographic (RP-HPLC) determination of sulfamethoxazole, trimethoprim and preservatives, as well as degradation products of sulfamethoxazole ...
Pharmacoeconomic evaluation of providing pharmacist-managed anticoagulation service to patients on warfarin / Farmakoekonomska evaluacija pružanja farmaceutske usluge pacijentima na antikoagulantnoj terapiji varfarinom
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
It has been determined that Pharmacist-Managed Anticoagulation Service (PMAS) for patients on warfarin improves anticoagulation control and decreases the rate of bleeding, thus reducing the overall health care costs. This ...
Drugs for rare diseases: An example of modified glucocerebrosidase / Lekovi za retke bolesti - primer modifikovane glukocerebrozidaze
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
To date, circa 5000 rare diseases have been defined, which in sum affect approximately 6% of total population. The development of drugs for rare diseases is hampered by the limitation of specific knowledge availability and ...
Biopharmaceutical aspects of ciprofloxacin interactions with metallic ions / Biofarmaceutski aspekti interakcije ciprofloksacina i jona metala
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
The ciprofloxacin - metallic ions interactions are well documented and described in the literature. In vivo studies show that ciprofloxacin bioavailability is reduced in the presence of metallic ions containing preparations. ...
Robustness testing of liquid chromatographic method for determination of itraconazole and its impurities applying fractional factorial design / Testiranje robusnosti metode tečne hromatografije za određivanje itrakonazola i njegovih nečistoća primenom frakcionog faktorskog dizajna
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Test of robustness is a part of the method validation and it is carried out in the end of the method development or in the beginning of the method validation. The purpose of robustness testing is to avoid problems in ...
Development of therapeutic monoclonal antibodies: From the mouse to the human / Razvoj monoklonskih antitela za terapijsku primenu - od mišjih do humanih
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Therapeutical monoclonal antibodies (mAbs) represent one of the fastest growing area of the pharmaceutical industry. High target specificity and specific molecular structure are features that make antibodies attractive ...
Effects of dermocosmetic/cosmetic products for skin lightening: What is real to expect? / Efekti dermokozmetičkih/kozmetičkih preparata za posvetljivanje kože - šta je realno očekivati?
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Hyperpigmentation is the disorder of skin color, hair color, nails and mucous membranes resulting from the increased amount of melanin in these areas, and it is characterized as dark areas, often seeming unacceptable. The ...
Vitamins in cosmetic products: Current opinions and practice / Vitamini u kozmetičkim proizvodima - savremeni stavovi i praksa
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Vitamins A, E, C, B3 and provitamin B5 (panthenol), and their numerous derivatives are most widely used in cosmetic products. Cosmetic retinoids (retinol, retinaldehyde, and retinyl esters) have been used for years in ...
Medicinal products used in dermatology: Classification and mechanisms of action / Lekovi za dermatološku primenu - klasifikacija i mehanizmi dejstva
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Medicinal products used to treat dermatology diseases can be applied topically or systemically, which offers the possibility of various therapeutic modifications. However, skin changes are numerous and also very common in ...
New anticoagulant drugs / Novi antikoagulantni lekovi
(Srpsko lekarsko društvo - Okružna podružnica Kragujevac, Kragujevac, 2012)
Anticoagulants are effective agents for the prevention and treatment of thrombosis and thromboembolic complications, which represent a common cause of morbidity and mortality. Despite their clinical efficiency, traditional ...